Just wondering if anyone is researching and following the small start-up company Novelos Therapeutics (NVLT.OB)? They have a phase III registration trial in lung cancer that shoudl have enough events this year to be unblinded. Their drug NOV-002 may or may not be a major breakthrough.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar<